Details for New Drug Application (NDA): 019309
✉ Email this page to a colleague
The generic ingredient in VASOTEC is enalapril maleate. There are twenty-seven drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.
Summary for 019309
Tradename: | VASOTEC |
Applicant: | Biovail Labs Intl |
Ingredient: | enalaprilat |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019309
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1.25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Feb 9, 1988 | TE: | RLD: | Yes |
Expired US Patents for NDA 019309
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Biovail Labs Intl | VASOTEC | enalaprilat | INJECTABLE;INJECTION | 019309-001 | Feb 9, 1988 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription